Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Oral ivermectin is used off-label for stubborn Demodex blepharitis, but it is not the FDA-approved treatment for this eyelid condition. Here is what the research actually supports.
Albendazole's interactions hinge on absorption and liver enzyme activity, not simple incompatibility lists—understanding why changes what "safe combination" actually means.
Ivermectin paralyzes parasites by locking open chloride channels found only in invertebrate nerves and muscles. Here is what that mechanism does and does not explain about its approved uses.
Ivermectin is the WHO-backed mainstay treatment for river blindness, controlling the disease and protecting sight through repeated, weight-based dosing.
Hydroxychloroquine calms an overactive immune system by altering cell chemistry at the molecular level—explaining its real, proven roles and its limits.
Mebendazole is a first-line, well-studied treatment for intestinal roundworm infection. Here is what the clinical evidence actually shows about how well it works and how it's dosed.
Two long-established drugs from entirely different families, briefly paired in the headlines. Here is what each actually does, and why combining them requires real medical caution.
Doxycycline is one of the best-studied drugs for preventing malaria in travelers. Here is what the trials actually show, how to take it correctly, and what side effects to expect.
Albendazole is a cornerstone drug for cystic and alveolar hydatid disease, but it works slowly and is rarely enough on its own for large or complicated cysts.